Goal The goal of this program is to inform the participant of practical ways to prevent, identify, and manage the extravasation of anti-neoplastic agents. Objectives At the completion of this program the participant will be able to: 1. List antineoplastic agents known to be vesicants or irritants. 2. Identify the signs and symptoms of extravasation injury. 3. Recommend a procedure for the safe administration of vesicant medications. 4. Describe the appropriate management of antineoplastic-induced extravasation injury.
No takes yet. Share an insight, caveat, or question.
Mullin et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Hospital Pharmacy